IRIS
IANNONE, Florenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.520
AS - Asia 7.137
EU - Europa 5.355
SA - Sud America 1.895
AF - Africa 233
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 15
Totale 34.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.256
SG - Singapore 3.323
CN - Cina 1.627
BR - Brasile 1.626
HK - Hong Kong 1.031
SE - Svezia 1.008
RU - Federazione Russa 868
IT - Italia 747
FR - Francia 740
DE - Germania 613
VN - Vietnam 435
GB - Regno Unito 404
FI - Finlandia 380
UA - Ucraina 155
IN - India 142
CA - Canada 138
AR - Argentina 107
ID - Indonesia 97
MX - Messico 84
BD - Bangladesh 83
CI - Costa d'Avorio 80
BE - Belgio 70
ZA - Sudafrica 65
JP - Giappone 62
IQ - Iraq 60
TR - Turchia 56
AT - Austria 51
ES - Italia 49
PL - Polonia 49
EC - Ecuador 48
IE - Irlanda 47
NL - Olanda 37
PK - Pakistan 33
PY - Paraguay 29
CZ - Repubblica Ceca 28
LT - Lituania 28
VE - Venezuela 26
IR - Iran 24
MA - Marocco 23
SA - Arabia Saudita 19
CO - Colombia 17
UZ - Uzbekistan 16
EU - Europa 15
KE - Kenya 15
PH - Filippine 15
JO - Giordania 14
PE - Perù 13
EG - Egitto 12
AU - Australia 11
CH - Svizzera 11
AM - Armenia 10
CL - Cile 10
JM - Giamaica 10
AZ - Azerbaigian 9
DK - Danimarca 9
KZ - Kazakistan 9
BO - Bolivia 7
DZ - Algeria 7
NP - Nepal 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
HR - Croazia 6
KG - Kirghizistan 6
TH - Thailandia 6
TN - Tunisia 6
UY - Uruguay 6
LB - Libano 5
PA - Panama 5
RO - Romania 5
RS - Serbia 5
SN - Senegal 5
TW - Taiwan 5
BB - Barbados 4
BG - Bulgaria 4
BH - Bahrain 4
EE - Estonia 4
GF - Guiana Francese 4
IL - Israele 4
KR - Corea 4
MD - Moldavia 4
NI - Nicaragua 4
OM - Oman 4
QA - Qatar 4
AO - Angola 3
BY - Bielorussia 3
CR - Costa Rica 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
NO - Norvegia 3
PS - Palestinian Territory 3
PT - Portogallo 3
DM - Dominica 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
Totale 34.131
Salva come PNG Salva come JPEG
Città #
Fairfield 2.589
Ashburn 1.985
Woodbridge 1.845
Singapore 1.711
Houston 1.409
Chandler 1.364
Seattle 1.078
Hong Kong 1.022
Cambridge 936
Ann Arbor 922
Wilmington 815
Nyköping 800
Beijing 554
Jacksonville 431
Dallas 389
Lawrence 323
Roxbury 311
Munich 282
New York 273
Nanjing 256
Los Angeles 245
Bari 219
Des Moines 201
Princeton 175
Inglewood 172
São Paulo 149
Ho Chi Minh City 138
Santa Clara 116
San Diego 114
Moscow 112
Buffalo 111
Helsinki 108
London 107
Brooklyn 104
Boardman 91
Hanoi 87
Dearborn 80
Abidjan 79
Turku 79
Chicago 75
Shenyang 75
Brussels 70
Paris 70
Jakarta 67
The Dalles 62
Hebei 59
Columbus 56
Rio de Janeiro 54
Dong Ket 52
Jiaxing 52
Tokyo 52
Nanchang 51
Dublin 47
Council Bluffs 45
Warsaw 44
Montreal 43
San Jose 43
Toronto 43
Boston 42
Belo Horizonte 40
Denver 40
Johannesburg 40
Poplar 39
Tianjin 39
San Francisco 37
Changsha 36
Frankfurt am Main 35
Milan 35
Stockholm 34
Chennai 32
Brasília 31
Mexico City 31
Nuremberg 31
Redwood City 31
Atlanta 30
Falkenstein 29
Guangzhou 27
Phoenix 27
Dhaka 25
Manchester 25
Vienna 25
Pune 24
Orem 23
Shanghai 23
Curitiba 21
Baghdad 20
Campinas 20
Falls Church 20
Porto Alegre 20
Ankara 19
Jinan 19
Salt Lake City 19
Rome 18
Augusta 17
Guarulhos 17
Quito 16
Amsterdam 15
Da Nang 15
Haiphong 15
Mumbai 15
Totale 23.959
Salva come PNG Salva come JPEG
Nome #
A rare association of anti-alanine-transfer RNA synthetase (anti-PL12) syndrome and sporadic inclusion body myositis 213
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 208
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 192
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 184
No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan 177
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 175
Autophagy markers LC3 and p62 accumulate in immune‐mediated necrotizing myopathy 170
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 167
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 167
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 167
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 163
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 160
A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab 157
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 156
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 156
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 155
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 155
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 155
Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases 153
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease 152
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 152
Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies 150
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 147
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 146
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 146
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 145
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 145
Digital ulcers predict a worse disease course in patients with systemic sclerosis 145
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 141
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 141
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 141
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 140
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 140
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 139
AB0369 Adult-onset still’s disease treatment predictors at 1-year follow-up in a single rheumatologic centre experience 139
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 138
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 137
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 137
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 137
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 136
Leucocytoclastic vasculitis as onset symptom of ulcerative colitis 135
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 134
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 134
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 134
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study 134
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 133
Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features 133
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 132
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 132
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 132
AN UNWELCOME HOST IN THE PATHOGENESIS OF ARTHRITIDES 131
ANTI-TNFA THERAPY IN PSORIATIC ARTHRITIS: DIFFERENT RATE OF REMISSION IN POLYARTICULAR AND OLIGOARTICULAR SUBSETS 131
Orofacial Manifestations and Temporomandibular Disorders of Sjogren Syndrome: An Observational Study 130
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 129
Serum amyloid-A in Behçet's disease 128
Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group 128
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: Results from a collaborative project of 11 European biologic registers 127
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 127
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 126
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 125
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 125
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 125
Management of Small Vessel Vasculitides 124
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate 123
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 123
Chondrocytes treated with different shock wave devices 123
Analysis of subchondral cortical plate and trabecular bone in osteoarthritis experimentally induced in goat tibia. Preliminary results 122
Untangling the web of systemic autoinflammatory diseases 121
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 121
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: A multicenter randomized clinical trial 120
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts 120
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 120
Peripheral and central nervous system correlates in fibromyalgia 120
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 119
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: Data from GISEA, the Italian biologics register 118
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature 118
Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register) 117
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 117
ASSOCIATION OF SYSTEMIC SCLEROSIS AND PSORIATIC ARTHRITIS: A CASE REPORT 116
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. 116
Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings 116
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study 116
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 115
Early clinical response predicts low disease activity at one year in rheumatoid arthritis patients on treatment with certolizumab in real-life settings. An appraisal of the Italian registry GISEA 114
Obesity and Inflammation – Targets for OA Therapy 113
The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries 113
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 113
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis 113
Digital laser doppler flowmetry may discriminate "limited" from "diffuse" systemic sclerosis 112
Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: International recommendations 111
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice 110
Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: A case series 110
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 109
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 109
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA) 109
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 108
Update on the profile of the EUSTAR cohort: An analysis of the EULAR Scleroderma Trials and Research group database 108
A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study 107
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 107
Sarcoidosis presenting with Raynaud's syndrome: a case report 106
Totale 13.466
Salva come PNG Salva come JPEG
Categoria #
all - tutte 163.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.951 0 0 0 0 0 251 288 293 326 367 212 214
2021/20222.494 191 220 41 125 109 185 163 146 153 171 344 646
2022/20233.717 575 439 289 301 364 495 78 433 545 28 108 62
2023/20241.250 105 260 58 98 105 267 38 60 15 47 32 165
2024/20256.640 145 91 482 157 139 616 635 774 335 405 1.000 1.861
2025/20267.698 1.967 622 910 1.691 1.861 647 0 0 0 0 0 0
Totale 35.826